Technical Analysis for APLT - Applied Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 10.01 0.70% 0.07
APLT closed up 0.7 percent on Friday, May 24, 2019, on approximately normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical APLT trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Doji - Bullish? Reversal 0.00%
Multiple of Ten Bullish Other 0.00%
Multiple of Ten Bearish Other 0.70%
Hot IPO Pullback Bullish Swing Setup 0.10%
New 52 Week Closing High Bullish -0.40%
New 52 Week Closing High Bullish -0.10%
Multiple of Ten Bullish Other -0.10%
Up 3 Days in a Row Strength -0.10%
New 52 Week Closing High Bullish 1.01%

Older signals for APLT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy. The company’s preclinical stage products include AT-001 for acute myocardial infraction; AT-007 for treating galactosemia; AT-003 to treat diabetic retinopathy; and AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
Biopharmaceutical Organ Systems Diabetes Cardiovascular Disease Diabetes Mellitus Diabetic Retinopathy Diabetic Peripheral Neuropathy Preclinical Stage Products Novel Products Peripheral Neuropathy Retinopathy
Is APLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 24 Applied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective Aldose Reductase Inhibitor for Treatment of Diabetic Cardiomyopathy
May 21 Applied Therapeutics Inc (APLT) President and CEO Shoshana Shendelman Bought $1.3 million of Shares
May 14 Applied Therapeutics prices downsized IPO
May 8 Uber in driver’s seat as IPO market gears up for busiest week since 2015
See more APLT news...
Indicators
Indicator Value
52 Week High 10.25
52 Week Low 7.95
Average Volume 97,397
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.52
Resistance 3 (R3) 10.47 10.25 10.44
Resistance 2 (R2) 10.25 10.12 10.28 10.41
Resistance 1 (R1) 10.13 10.04 10.19 10.18 10.38
Pivot Point 9.91 9.91 9.94 9.94 9.91
Support 1 (S1) 9.79 9.78 9.85 9.84 9.64
Support 2 (S2) 9.57 9.70 9.60 9.61
Support 3 (S3) 9.45 9.57 9.59
Support 4 (S4) 9.50